Farringdon Capital’s Neurocrine Biosciences NBIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-2,318
Closed -$316K 514
2024
Q4
$316K Buy
+2,318
New +$316K 0.13% 264